The adult psychiatrist's dilemma: psychostimulant use in attention deficit/hyperactivity disorder

@article{Ashton2006TheAP,
  title={The adult psychiatrist's dilemma: psychostimulant use in attention deficit/hyperactivity disorder},
  author={Heather Ashton and Peter Gallagher and Brian Moore},
  journal={Journal of Psychopharmacology},
  year={2006},
  volume={20},
  pages={602 - 610}
}
Children who have taken psychostimulants long term for attention deficit/hyperactivity disorder (ADHD) are now presenting at adult psychiatry clinics at an age at which bipolar disorder and schizophrenia may first appear and at which pregnancy is a possibility. Doctors who may have little experience in the management of ADHD or use of psychostimulants are faced with decisions on whether to continue or withdraw medication. A literature search conducted to clarify these issues revealed that… Expand
Adult ADHD: Questioning Diagnosis and Treatment in a Patient with Multiple Psychiatric Comorbidities
TLDR
The potential benefits and adverse effects of stimulants in the treatment of adult ADHD and mood disorders are considered and the learning points of this complicated, but not uncommon, clinical case are reviewed. Expand
Bupropion for attention deficit hyperactivity disorder (ADHD) in adults.
TLDR
Low-quality evidence that bupropion decreased the severity of ADHD symptoms and increased the proportion of participants achieving clinical improvement is found, suggesting a possible benefit in clinical improvement in adults with ADHD. Expand
Safety of stimulant treatment in attention deficit hyperactivity disorder: part II
  • R. Merkel
  • Medicine
  • Expert opinion on drug safety
  • 2010
TLDR
This paper is a continuation of an earlier paper that reviewed the safety profile of newer stimulant agents, especially in relation to special populations, and is a thorough review of safety concerns in stimulants. Expand
State of the Art of Adult ADHD: Implications for Clinical Practice
Purpose: The goal of this paper is to review and discuss the current status of adult ADHD with respect to conceptualization, diagnosis and treatment. Method: Searches of PsycINFO and Medline wereExpand
A retrospective claims analysis of combination therapy in the treatment of adult attention-deficit/hyperactivity disorder (ADHD)
TLDR
ATX and LAS are the most likely drugs to be used as monotherapy in managing adult ADHD, and predictors of combination therapy for LAS and for ATX were modeled for patients covered by commercial plans. Expand
Evidence-based guidelines for management of attention-deficit/hyperactivity disorder in adolescents in transition to adult services and in adults: recommendations from the British Association for Psychopharmacology
TLDR
Initial guidance on managing ADHD in adolescents in transition and in adults is based on expert opinion derived from childhood evidence and it is hoped that, by the time these guidelines are updated, much evidence will be available to address the many directions for future research that are detailed here. Expand
Safety of therapeutic methylphenidate in adults: a systematic review of the evidence
  • J. Godfrey
  • Psychology, Medicine
  • Journal of psychopharmacology
  • 2009
TLDR
There is little information on the long-term safety of methylphenidate in adults, although the number of serious adverse effects reported to regulatory authorities has, so far, been low. Expand
The Retrospective Diagnosis of Attention-Deficit/Hyperactivity Disorder in Adolescents: Family Physicians' Challenges
TLDR
The sources of information currently utilized by physicians for conducting a retrospective diagnosis of ADHD in adolescents were assessed as well as patterns of differences in treatment practices based on the preferred sources of assessment information utilized. Expand
European consensus statement on diagnosis and treatment of adult ADHD: The European Network Adult ADHD
TLDR
This Consensus Statement is one of the actions taken by the European Network Adult ADHD in order to support the clinician with research evidence and clinical experience from 18 European countries in which ADHD in adults is recognised and treated. Expand
Safety of stimulant treatment in attention deficit hyperactivity disorder: part I
TLDR
The use of the newer stimulant agents shows a safety profile of frequent, but usually mild side effects that are generally safe in special populations and the risk of developing long-term substance abuse with attention deficit hyperactivity disorder is small and may decrease with proper treatment. Expand
...
1
2
3
...

References

SHOWING 1-10 OF 129 REFERENCES
Attention-deficit/hyperactivity disorder and the substance use disorders: the nature of the relationship, subtypes at risk, and treatment issues.
  • T. Wilens
  • Medicine
  • The Psychiatric clinics of North America
  • 2004
TLDR
Although the existing literature has provided important information on the relationship of ADHD and SUD, it also points to a number of areas in need of further study, and the mechanism by which untreated ADHD leads to SUD and the risk reduction of ADHD treatment on later SUD needs to be understood better. Expand
Stimulants: use and abuse in the treatment of attention deficit hyperactivity disorder.
  • K. Fone, D. Nutt
  • Psychology, Medicine
  • Current opinion in pharmacology
  • 2005
TLDR
Preclinical studies have begun to use lower clinically relevant doses and oral administration of psychostimulants to determine their long-term effect on development, behaviour and neurochemistry, which is an important public health issue associated with chronic medication of adolescents with ADHD. Expand
Attention-deficit/hyperactivity disorder in adults: a survey of current practice in psychiatry and primary care.
TLDR
Data contained within this medical record review suggest that adult ADHD is a substantial source of morbidity in both psychiatric and PCP settings. Expand
Does stimulant therapy of attention‐deficit/hyperactivity disorder beget later substance abuse?
TLDR
It is suggested that stimulant therapy in childhood is associated with a reduction in the risk for subsequent drug and alcohol use disorders. Expand
Adderall-induced psychosis in an adolescent.
TLDR
To date, there have been no published reports of psychotic reactions to amphetamine (Adderall) in an adolescent patient, and a search of MEDLINE and pre-MEDLINE using keywords including “ Adderall,” “ methamphetamine,’ “dextroamphetamine,�” and “psychosis” found no reports. Expand
Patterns of psychiatric comorbidity with attention-deficit/hyperactivity disorder.
  • S. Pliszka
  • Medicine
  • Child and adolescent psychiatric clinics of North America
  • 2000
TLDR
The prevalence of major depressive disorder (MDD) and bipolar disorder among children with ADHD is controversial, but there clearly exists a subgroup of severely emotionally labileChildren with ADHD who present serious management issues for the clinician. Expand
Prevalence and Characteristics of Adolescent Patients with Co-Occurring ADHD and Substance Dependence
TLDR
Results indicate 31% of patients have current ADHD diagnosis and 20% reported illicit diversion of Schedule II medication, which may be risky for an SUD population since individuals with SUD may have a higher likelihood of abusing or diverting the medications. Expand
Attention-deficit hyperactivity disorder
TLDR
Converging evidence from animal and human studies implicates the dysregulation of frontal-subcortical-cerebellar catecholaminergic circuits in the pathophysiology of ADHD, and molecular imaging studies suggest that abnormalities of the dopamine transporter lead to impaired neurotransmission. Expand
Attention-Deficit/Hyperactivity Disorder in Adults
• Objective: To review the diagnosis and treatment of attention-deficit/hyperactivity disorder (ADHD) in adults. • Methods: Qualitative assessment of the literature. • Results: ADHD in adults isExpand
Pharmacotherapy of Attention-deficit/Hyperactivity Disorder Reduces Risk for Substance Use Disorder
TLDR
Untreated ADHD was a significant risk factor for SUD in adolescence in boys with attention-deficit/hyperactivity disorder and pharmacotherapy was associated with an 85% reduction in risk for Sud in ADHD youth. Expand
...
1
2
3
4
5
...